Managing diabetes in the elderly: Go easy, individualize

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 1, 2008, Pages 70-78

  Hornick, Thomas ^a,b   Aron, David C ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

AGE; AGED; ARTICLE; DIABETES MELLITUS; GERIATRIC ASSESSMENT; GLUCOSE BLOOD LEVEL; HUMAN; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; GERIATRIC ASSESSMENT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; UNITED STATES;

EID: 39749147092     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.1.70     Document Type: Review

References (66)

1. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997; 46:701-710.
2. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci 2001; 56:M5-M13.
3. Rodriguez A, Muller DC, Engelhardt M, Andres R. Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. Metabolism Clin Exper 2005; 54:542-547.
4. Crandall J, Barzilai N. Treatment of diabetes mellitus in older people: oral therapy options. J Am Geriatr Soc 2003; 51:272-274.
5. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21:518-524.
6. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Diabetes Public Health Resource. National Diabetes Surveillance System. www.cdc.gov/diabetes/ statistics/prev/national/figbyage.htm.
7. Franse LV, Di Bari M, Shorr RI, et al; Health, Aging, and Body Composition Study Group. Type 2 diabetes in older well-functioning people: who is underdiagnosed? Data from the Health, Aging, and Body Composition study. Diabetes Care 2001; 24:2065-2070. Erratum in: Diabetes Care 2002; 25:413.
8. Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC, Pahor M. Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 2000; 48:264-267.
9. Smith NL, Savage PJ, Heckbert V, et al. Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study. J Am Geriatr Soc 2002; 50:416-423.
10. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993; 48:M117-M121.
11. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28:S4-S36.
12. Motta M, Bennati E, Ferlito L, Malaguarnera M. Diabetes mellitus in the elderly: diagnostic features. Arch Gerontol Geriatr 2006; 42:101-106.
13. Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost effective analysis. Ann Intern Med 2004; 140:689-699.
14. Harris RP, Lux LJ, Bunton AJ, et al. Screening for type 2 diabetes mellitus. Systematic Evidence Review Number 19. February 4, 2003 US Department of Health and Human Services, Agency for Healthcare Research and Quality. Rockville, MD. www.ahrq.gov/downloads/pub/prevent/pdfser/ diabser.pdf.
15. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care foiF Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51:S265-S280.
16. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus in the Primary Care Setting 2003. www.oqp.med.va.gov/cpg/dm/ DM3∐g/content/introduction.htm.
17. Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 2006; 295:1935-1940.
18. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276:1886-1892. Erratum in: JAMA 1997; 277:1356.
19. Goddijn PP, Blio HJ, Feskens EJ, Groeniert KH, van der Zee KI, Meyboom-de Jong B. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control. Diabet Med 1999; 16:23-30.
20. Pyorala K. Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A sub-group analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20:614-620. Erratum in: Diabetes Care 1997; 20:1048.
21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853. Erratum in: Lancet 1999; 354:602.
22. Katakura M, Naka M, Kondo T, at al, and the Nagano Elderly Diabetes Study Group. Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: outcome of 6-year prospective study. Diabetes Res Clin Practice 2007;78:108-114.
23. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 340.393-403.
24. Pogach LM, Brietzke SA, Cowan CL Jr, Conlin P, Walder DJ, Sawin CT, VA/DoD Diabetes Guideline Development Group. Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative. Diabetes Care 2004; 27:B82-B89.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
26. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-713. Erratum in: BMJ 1999; 318.29.
27. 1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 2007;147:417-422.
28. 1c goals in diabetes care: pass/fail or partial credit. JAMA 2007; 297:520-523.
29. Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997; 14:919-928.
30. Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus. JAMA 1998; 279:137-143.
31. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999; 159:281-284.
32. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44:751-755.
33. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157:1681-1685.
34. Burge MR, Kamin JR, Timm Cr, Qualls CR, Schade DS. Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes. Metabolism 2000; 49:195-202.
35. Alagiakrishnan K, Lechelt K, McCracken P, Torrible S, Sclater A. Atypical presentation of silent nocturnal hypoglycemia in an older person. J Am Geriatr Soc 2001; 49:1577-1578.
36. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632.
37. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
38. Metchick LN, Petit WA Jr, Inzucchi SE. Inpatient management of diabetes mellitus. Am J Med 2002; 113:317-323.
39. Coulston AM, Mandelbaum D, Reaven GM. Dietary management of nursing home residents with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1990; 51:67-71.
40. Song MK, Rosenthal MJ, Naliboff BD, Phanumas L, Kang KW. Effects of bovine prostate powder on zinc, glucose and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism 1998; 47:39-43.
41. Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993; 16:1433-1437.
42. Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4 week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78:1510-1514.
43. Paolisso G, Passariello N, Pizza G, et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol (Copenh) 1989; 121:16-20.
44. Paolisso G, D'Amore A, Balbi V, et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 1994; 266:E261-E268. Erratum in: Am J Physiol 1994; 267:section E following table of contents.
45. Agurs-Collins TD, Kumanyika SK, Ten Have TR, Adams-Campbell LL. A randomized controlled trail of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care 1997; 200:1503-1511.
46. Skarfors ET, Wegener TA, Lithell H, Selinus I. Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men. A feasibility study over 2 years. Diabetologia 1987; 30:930-933.
47. Raz I, Hauser E, Bursztyn M. Moderate exercise improves glucose metabolism in uncontrolled elderly patients with non-insulin-dependent diabetes mellitus. Isr J Med Sci 1994; 30:766-770.
48. Brodows RG. Benefits and risks with glyburide and glipizicle in elderly NIDDM patients. Diabetes Care 1992; 15:75-80.
49. Landgraf R. Meglitinide analogues in the treatment of type 2 diabetes mellitus. Drugs Aging 2000; 17:411-425.
50. Ron Y, Wainstein J, Leibovitz A, et al. The effect of acarbose on the colonic transit time of elderly long-term care patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2002; 57:M111-M114.
51. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007; 147:386-399.
52. Rosenstock J. Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001; 18:31-44.
53. Gerstein HC, Haynes RB, eds. Evidence-Based Diabetes Management. Hamilton, Ont.; London: B.C. Dekker; 2001.
54. Tovi J, Engfeldt P. Well being and symptoms in elderly type 2 diabetes patients with poor metabolic control: effect of insulin treatment. Practical Diabetes Int 1998; 15:73-77.
55. Reza M, Taylor CD, Towse K, Ward JD, Hendra TJ. Insulin improves well-being for selected erderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002; 55:201-107.
56. Janka HU, Plewe G, Busch K. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus. J Am Geriatrics Soc 2007; 55:182-188.
57. Coscelli C, Calabrese G, Fedele D, et al. Use of premixed insulin among the elderly. Reduction of errors in patient preparation of mixtures. Diabetes Care 1992; 15:1628-1630.
58. Rolla AR, Rakel RE. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues. Clin Ther 2005; 27:1113-1125.
59. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005; 28:1092-1100.
60. Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005; 28:1083-1091.
61. Mathieu C, Bollaerts K. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics, and DPP-4 inhibitors. Int J Clin Pract 2007; 61 (suppl 154):29-37.
62. Bernbaum M, Albert SG, McGinnis J, Brusca S, Mooradian AD. The reliability of self blood glucose monitoring in elderly diabetic patients. J Am Geratr Soc 1994; 42:779-781.
63. Gilden JL, Hendryx M, Casia C, Singh SP. The effectiveness of diabetes education programs for older patients and their spouses. J Am Geriatr Soc 1989; 37:1023-1030.
64. Glasgow RE, Toobert DJ, Hampson SE, Brown JE, Lewinsohn PM, Donnelly J. Improving self-care among older patients with type II diabetes: the 'Sixty Something...' Study. Patient Educ Couns 1992; 19:61-74.
65. Huang ES, Gorawara-Bhat R, Chin MH. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005; 53:306-311.
66. Langa KM, Vijan S, Hayward RA, et al. Informal caregiving for diabetes and diabetic complications among elderly Americans. J Gerontol B Psychol Sci Soc Sci 2002; 57:S177-S186.